Monograph Details
|
|
Hematology
> Anemias
|
|
LUPRON DEPOT-3 MONTH 11.25mg |
| Manufacturer |
|
TAP Pharmaceutical Products, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
GnRH analogue. |
| Generic Name |
|
Leuprolide acetate 11.25mg; depot susp for IM inj; preservative-free. |
| Also |
|
• LUPRON DEPOT 3.75mg
|
| Indications |
|
Presurgical treatment of patients with anemia due to uterine leiomyomata (fibroids), with iron therapy if iron therapy alone is inadequate. |
| Children |
<18 years: not applicable.
|
| Adults |
|
≥18 years: 11.25mg IM once every 3 months (1 injection). Do not split doses. |
| Contraindications |
|
Undiagnosed abnormal vaginal bleeding. Pregnancy (Cat.X). Nursing mothers. |
| Precautions |
|
Exclude pregnancy before starting; use nonhormonal contraception during therapy; discontinue if pregnancy occurs. Risk factors for decreased bone mineral density (eg, chronic alcohol, tobacco, anticonvulsants, corticosteroids). Missing successive doses may cause breakthrough bleeding or ovulation. Elderly. |
| Adverse Reactions |
|
Hot flashes, headache, vaginitis, depression, emotional lability, pain, decreased libido, breast changes, amenorrhea, mastodynia, joint disorder, asthenia, GI upset, edema, bone density loss, local reactions, acne, memory disorders, others; rarely: anaphylaxis, asthma, increased serum transaminases or lipids. |
| How Supplied |
|
Kit—1 (single-dose syringe w. diluent, supplies) |
|
|
|
|
